Luminous Ventures invests in Optellum
Optellum, developer of an AI software platform that enables doctors to diagnose, treat and cure lung cancer patients at the earliest stages of disease, has secured 1 million pounds in funding. The backer is Luminous Ventures.
15 July 2019•3 mins read
